IL2 and colorectal cancer: Moreover, after IL-2 treatment of colorectal cancer patients (after treatment), Treg cells had equal suppressive function on conventional CD4+CD25− T-cell proliferation when compared to Treg cells isolated before start of therapy (light grey bar, Fig. 3C, p<0.001).